Trigeminal neuralgia
Conditions
Interventions
Group N:Midazolam injection for sedation
Group D:dexmedetomidine hydrochloride nasal spray for sedation
Sponsors
The Second Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: (1) Patients with primary trigeminal neuralgia; (2) ASA classification I–III; (3) Age >= 18 years; (4) Patients are aware of the purpose and procedures of this study, cooperate in completing scale assessments, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with secondary trigeminal neuralgia; (2) Patients who cannot receive intranasal administration, such as those with nasal surgery or trauma; (3) Patients allergic to this product or its components; (4) Circulatory system disorders, such as hypotension, bradycardia, or sinus arrest; (5) Patients with concurrent immune system or endocrine system diseases, or dysfunction of major organs including heart, brain, lungs, liver, or kidneys; (6) Allergy to related anesthetic drugs; (7) Patients who cannot complete scale assessments or refuse to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PAS-7 Score;RSS Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of severe adverse reactions after surgery;Incidence and severity of nausea and vomiting; | — |
Countries
China
Contacts
Public ContactJunpeng Liu
The Second Hospital Of Hebe Medical University
Outcome results
None listed